Very early researchStudy completedNCT02484053
What this trial is testing
Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders
Who this might be right for
Hematologic DisordersOncologic DisordersRheumatologic Disorders
Baylor College of Medicine 20